Suite CPG Tre
Suite CPG Tre is a cloud-based digital pathology platform from Italian vendor Cloud Pathology Group. It digitises, stores and displays histology slides, connects to laboratory systems over HL7, and adds AI modules for breast and colorectal image analysis.
What is Suite CPG Tre?
Suite CPG Tre is the digital pathology platform released in 2024 by Cloud Pathology Group, a company founded in Milan on 16 February 2012 with a second research site in Catania. The vendor describes itself on its home page as the only Italian company offering an integrated solution to anatomic pathology departments, delivered as Software as a Service.
The suite is organised around three functional blocks, named on the product page as Workflow, Visualization and Database. Its stated architectural principles are ease of use, with a redesigned interface and built-in online help; modularity, built on microservices; low cost of ownership, through open-source technologies; flexibility, since the system is parameterised from the front end rather than in code; standardisation, receiving case data from laboratory information systems over the HL7 protocol; openness to any LIS and any slide scanner; horizontality, acting as a front end from which other daily systems can be launched; and accessibility through responsive design, so a pathologist can read on dual monitors while consulting reports on a phone or tablet. A knowledge repository keeps images and data on a multi-tier architecture described as never allowing deletion.
Three AI modules sit inside or alongside it. CPG-AI Breast Nuclei and CPG-AI Breast HER2 use machine learning to quantify nuclear positivity such as Ki67 and ER, and membrane HER2 positivity, on DAB-stained immunohistochemistry; the vendor stresses that these algorithms are calibrated on each laboratory's own staining. CPG-AI Colorectal Onco Assistant, built with deep learning under the DiOncoGen project, annotates haematoxylin-eosin slides and reports the regions that deserve the pathologist's attention, distinguishing adenocarcinomas, dysplasias and lymphocyte aggregates with statistical values the vendor puts above 90 per cent. That module is marked for research use only.
Two human services surround the software: a customer care team dedicated to digital pathology, supporting both laboratory staff and hospital IT departments, and consulting on project design and process optimisation. All of the above was read on archived captures of the site dated between January and June 2026; the vendor's server no longer answered when this entry was compiled on 4 September 2026.
What it does
- Digitise histology slides and manage them in a single online archive
- Read whole-slide images from a browser, on a dual-screen workstation or a tablet
- Score nuclear positivity (Ki67, ER) and membrane positivity (HER2) on DAB immunohistochemistry
- Have colorectal haematoxylin-eosin slides annotated automatically, with regions of interest flagged for review
- Receive case data from the laboratory information system over HL7, without re-keying
- Consult colleagues' reports, usage statistics and access logs according to permissions
- Configure the platform from the front end, without touching code
When to use Suite CPG Tre / When not to
A quick filter to help you decide if Suite CPG Tre is the right fit.
When to use Suite CPG Tre
- Hospital pathology departments moving from glass slides to a fully digital histology routine
- Laboratory managers who want digital pathology in SaaS mode, without buying hardware or hiring an IT team
- Multi-site laboratory networks needing one shared image archive across several hospitals, as in the Insubria network CPG was awarded in 2020
- Pathologists who need quantitative scoring of nuclear (Ki67, ER) and membrane (HER2) immunohistochemistry rather than visual estimation
- Healthcare IT teams whose laboratory information system already speaks HL7 and who need it wired to a slide viewer
When not to use Suite CPG Tre
- Anyone looking for an autonomous diagnostic engine: the colorectal AI module is labelled for research use only
- Buyers who need a published price before they will start a conversation, since every figure goes through a quotation
- Departments outside anatomic pathology, as the vendor deliberately positions the suite as a single-speciality product
- Development teams expecting a documented product API to build on, which the vendor does not publish
- Procurement teams that require published contractual terms up front, because the site carries no terms and conditions at all
How to use Suite CPG Tre
A typical end-to-end flow, from setup to results.
- Note first that the vendor's website did not respond on 4 September 2026, so none of the steps below can currently be completed online
- Open the contact form, which lives as an anchor on the team page rather than on a page of its own
- Choose the purpose of the request among appointment, demo, quotation and other
- Accept the privacy notice through the mandatory checkbox before the form can be sent
- Discuss scope with the vendor, since there is no self-service signup, no trial and no published price
- Agree an integration plan covering the laboratory information system, which must speak HL7, and the slide scanners in use
- Follow the preparatory support programme the vendor offers ahead of adopting digital pathology
- Have the platform configured from its front end, which the vendor states requires no code changes
- Work day to day from a browser, with dual monitors recommended for slide reading
- Use a phone or tablet to consult reports, usage statistics and access logs, subject to permissions
Pros & Cons
Pros
- Tightly focused on one clinical speciality, which the vendor claims as a design choice rather than a limitation
- Publishes its own certificates rather than merely claiming them: ISO/IEC 27001, 27017 and 27018 issued by RIGCERT, plus ISO 9001 obtained after a TUV audit in the first half of 2024
- Interoperates through the open HL7 standard, described as covering every laboratory information system on the Italian market
- Delivered as SaaS, so a laboratory needs neither capital equipment nor extra IT headcount
- Backs its claims with named public deployments, at the Nuovo Ospedale degli Infermi in Biella from 2018 and across the Insubria hospital network from 2020
- Research is anchored to a public partner, the ISTI-CNR institute in Pisa, and to a dedicated Catania laboratory
- Registers its software with SIAE, the Italian copyright registry, and publishes the deposit certificates
Cons
- The vendor's server did not answer at all on 4 September 2026, on any host tested, although the web archive shows the site serving normally on 11 June 2026 and no page ever announced a shutdown
- No price, no plan and no order of magnitude is published anywhere, and the absence is confirmed by the site's own nine-page sitemap
- There are no terms and conditions: the page whose title and address promise them contains only a privacy notice, yet the contact form asks visitors to accept terms that are published nowhere
- The privacy notice is written entirely in Italian even at its English address, so there is no English-language legal text at all
- Nothing is published about where customer data is hosted, how long it is kept, which subprocessors are involved, or whether a data processing agreement exists
- The CE-IVD marking is self-certified by the vendor rather than assessed by a notified body, and the colorectal module is restricted to research use
- The delivered site is visibly unmaintained: broken internal links, leftover absolute URLs pointing at the web agency's staging domain, and a banner still advertising the previous product generation alongside the current one
Pricing & Plans
No price is published. Cloud Pathology Group does not operate a pricing page, and the absence is not a gap in this review: the site's own sitemap lists only nine pages, and a complete inventory of the domain in the web archive confirms that no pricing page has ever existed. There is likewise no mention of a free plan, a freemium tier or a free trial, in either direction, so neither can be affirmed nor denied. The only commercial signal on the site is the quotation option offered in the contact form, alongside appointment and demonstration requests. Commercial terms are therefore established case by case, which is consistent with a product sold to hospital departments as an integration project. Since no amount and no currency are published, this entry carries no starting price, no currency and no billing unit.
Data, GDPR & hosting
A consolidated view of how Suite CPG Tre handles your data.
GDPR overview
GDPR compliance is claimed explicitly but narrowly. The privacy notice is issued under Article 13 of Regulation (EU) 2016/679 and lists the data subject rights of access, rectification, erasure, restriction, objection and portability, citing Articles 15, 16, 17, 18, 20 and 21. Consent can be withdrawn at any time without affecting earlier processing. Rights are exercised at info@cloudpathology.eu or by registered letter to the Milan office. No data protection officer is named, and no Article 27 representative is designated, which is consistent with a controller established in Italy. Two gaps matter: the notice carries no effective date, and it never mentions the clinical product, so there is no GDPR statement covering the slides and patient data the suite processes. The vendor separately publishes ISO/IEC 27001, 27017 and 27018 certificates issued to it by RIGCERT.
Who owns the data?
The site never settles this. The only legal document Cloud Pathology Group publishes is a privacy notice, and it covers visitors to the website alone: browsing data, and whatever a reader types into the contact form. It names Cloud Pathology Group, Via Lanzone 4, Milan, as the data controller, and says browsing data is collected in anonymous form. Nothing on the site addresses the clinical material the product actually handles, that is, the digitised slides and the patient records attached to them. There is no ownership clause, no processing agreement and no customer-facing contract anywhere on the nine pages the site publishes. Prospective buyers should treat slide and patient data ownership as an open contractual question, to be settled in writing before any deployment. Reviewed from archived captures of the site dated June 2026.
Reuse rights
Because the vendor publishes no terms and conditions, there is no statement anywhere granting or restricting a customer's right to reuse their own data. The published privacy notice speaks only about the website: browsing data feeds anonymous usage statistics and site monitoring, and may be used to establish liability if the site is attacked; form submissions are processed only after explicit consent; data is not disclosed except where law or EU regulation requires it. On the product side the picture is different and worth knowing. The vendor states that the image-analysis algorithms are calibrated on the staining characteristics of each individual laboratory using machine learning, so that every customer ends up with models tuned on its own slides. That is customer data being used to train models, described as a product feature rather than as a governance commitment, and it is not accompanied by any opt-out. Recorded from captures dated May and June 2026.
Data retention & training
Hosting summary
Cloud Pathology Group publishes no hosting information. No country, no region and no cloud provider is named anywhere on the site for customer or clinical data, and the privacy notice restricts itself to website browsing data without addressing where anything is stored. Two indications exist but neither settles the question and neither should be mistaken for an answer. The vendor holds ISO/IEC 27017 and 27018 certificates, which concern cloud security and the protection of personal data in public cloud environments, so a cloud deployment is implied without being located. Separately, the website's own IP address resolved to Milan on Amazon infrastructure when checked on 4 September 2026, but that describes where the marketing site was served, not where digitised slides or patient records are held. Given that the product is sold to Italian public hospitals, the jurisdiction question is material and should be put to the vendor in writing.
Things to keep in mind
Risks and trade-offs to weigh before adopting Suite CPG Tre.
- The vendor's website did not respond on 4 September 2026 although it was serving normally on 11 June 2026; everything described here comes from dated archive captures rather than from a live site, and the company's current status should be confirmed independently
- Clinical safety: the colorectal module is restricted to research use and the CE-IVD marking is self-declared by the vendor, so neither should be read as third-party validation of diagnostic performance
- Automation bias: a tool that pre-annotates regions of interest can quietly narrow where a pathologist looks, and the vendor's own above-90-per-cent figures describe classification statistics, not clinical outcomes
- Contractual exposure: with no published terms, no data processing agreement and no stated hosting jurisdiction, the obligations around patient data would have to be negotiated from scratch
- Retention: the privacy notice promises to keep data only as long as necessary, while the product page describes a knowledge repository built so that data is never deleted; the two statements cover different data but the gap deserves a direct question
- Model calibration on customer material: the vendor states that algorithms are tuned on each laboratory's own slides through machine learning, and offers no documented way to decline
- Third-party achievements are not the vendor's: the hospitals named as deployments and the ISTI-CNR research institute are customers and partners, and RIGCERT and TUV are the certification bodies, not the company itself
Setup & Integrations
Technical difficulty
Moderate, and always a project rather than a self-service setup. There is no signup, so deployment begins with a commercial conversation. The main prerequisites are a laboratory information system able to exchange data over HL7 and one or more slide scanners, both of which the vendor claims to support broadly. Configuration is then done from the front end, with no code changes required. The vendor offers a preparatory support programme before adoption and continuous support for the contract term, and sells consulting precisely because digitising a pathology department means redesigning its processes. Day to day, users need only a browser.
Deployment
Behind Suite CPG Tre
Resources
All the official URLs gathered for verification and reference.
Frequently asked questions
What is Suite CPG Tre?
Who is behind the product?
Which AI modules does it include?
Can the colorectal module be used for routine diagnosis?
How much does it cost?
How does it fit into an existing laboratory?
Is there an API for developers?
Where is customer data hosted, and how long is it kept?
What certifications does the vendor hold?
Is the website still online?
Should you pick Suite CPG Tre?
Suite CPG Tre is a credible, narrowly focused product from a vendor with a twelve-year track record and verifiable public deployments, from the hospital in Biella in 2018 to the Insubria laboratory network from 2020. Its information security file is unusually solid for a company of this size: three ISO certificates published as documents rather than asserted as logos, plus ISO 9001 after a TUV audit, all issued to Cloud Pathology Group itself. The AI modules are described with enough technical detail to be assessed, including the admission that the colorectal model is for research use only and that the CE-IVD marking is self-declared.
Against that, the commercial and contractual side is thin. No price is published, which is normal for this market, but neither are any terms and conditions, and the site nonetheless asks visitors to accept terms it never provides. Nothing is said about where clinical data lives, how long it is kept or who else processes it, and the one legal document on the site addresses website visitors rather than the product.
One reservation overrides the rest, and it is a dated observation rather than a judgement. On 4 September 2026 the vendor's server did not respond on any tested host, while the web archive shows the site being served normally on 11 June 2026. The domain is still registered and still resolves, and no page has ever announced a closure, so this entry describes a product whose public presence has gone quiet for reasons the site itself does not explain. Anyone considering the suite should confirm that the company is still trading before entering discussions, and should read every fact here as describing the site as it stood in mid-2026.
- Choosing a selection results in a full page refresh.
- Opens in a new window.